Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun;26(6):1119-1131.
doi: 10.1007/s11605-022-05295-z. Epub 2022 Mar 31.

Long-term Outcomes Following Esophagectomy in Older and Younger Adults with Esophageal Cancer

Affiliations

Long-term Outcomes Following Esophagectomy in Older and Younger Adults with Esophageal Cancer

Aaron R Dezube et al. J Gastrointest Surg. 2022 Jun.

Abstract

Background: Patterns of overall and disease-free survival after esophagectomy for esophageal cancer in older adults have not been carefully studied.

Methods: Retrospective analysis of all patients with esophageal cancer undergoing esophagectomy from 2005 to 2020 at our institution was performed. Differences in outcomes were stratified by age groups, < 75 and ≥ 75 years old, and two time periods, 2005-2012 and 2013-2020.

Results: A total of 1135 patients were included: 979 (86.3%) patients were < 75 (86.3%), and 156 (13.7%) were ≥ 75 years old. Younger patients had fewer comorbidities, better nutritional status, and were more likely to receive neoadjuvant and adjuvant therapy (all p < 0.05). However, tumor stage and operative approach were similar, except for increased performance of the McKeown technique in younger patients (p = 0.02). Perioperatively, younger patients experienced fewer overall and grade II complications (both p < 0.05). They had better overall survival (log-rank p-value < 0.001) and median survival, 62.2 vs. 21.5 months (p < 0.05). When stratified by pathologic stage, survival was similar for yp0 and pathologic stage II disease (both log-rank p-value > 0.05). Multivariable Cox models showed older age (≥ 75 years old) had increased hazard for reduced overall survival (HR 2.04 95% CI 1.5-2.8; p < 0.001) but not disease-free survival (HR 1.1 95% CI 0.78-1.6; p = 0.54). Over time, baseline characteristics remained largely similar, while stage became more advanced with a rise in neoadjuvant use and increased performance of minimally invasive esophagectomy (all p < 0.05). While overall complication rates improved (p < 0.05), overall and recurrence-free survival did not. Overall survival was better in younger patients during both time periods (both log-rank p < 0.05).

Conclusions: Despite similar disease-free survival rates, long-term survival was decreased in older adults as compared to younger patients. This may be related to unmeasured factors including frailty, long-term complications after surgery, and competing causes of death. However, our results suggest that survival is similar in those with complete pathologic responses.

Keywords: Esophagectomy; Older adults; Outcomes; Recurrence; Survival.

PubMed Disclaimer

Conflict of interest statement

Declarations

Conflicts of interest Doctors Aaron R. Dezube, Luis E. De-Leon, Suden Kucukak, Lisa Cooper, Daniel Dolan, Michael T. Jaklitsch, Abby White, Bayonle Adenoma, Laura Frain, and Jon O. Wee have no conflicts of interest or financial ties to disclose as well as Mr. Daniel N. Lee and Ms. Emily Polhemus. Dr. Swanson is a consultant for Ethicon. Dr. Bueno has grants from NCI, NIBIB, NHLBI, DoD, Roche, Genetech, Merck, Siemens, Verastem, Gristone, Northpond, Epizyme, and Intuitive Surgical as well as receives consulting fees from Regeneron and receives payment for expert testimony to Thornton Law Firm LLP, Blakinship & Keith, PC, Dolan Dobrinsky Rosenblum and Bluestein, Kelley and Uustal, Foster & Eldridge LLP, and Adler Cohen Harvey Wakeman Guekguezian LLP; he further has patents licensed to BWH and participates on Data Safety Monitoring Board or Advisory Board for Novocure; finally, he has equity in Navigation Sciences. Emanuele Mazzola receives consulting feeds from the VeraMedica Institute LLC.

Figures

Fig. 1
Fig. 1
Kaplan–Meier overall survival after esophagectomy by age
Fig. 2
Fig. 2
Kaplan–Meier disease-free survival by age. a Overall disease-free survival; b local–regional disease-free survival; c distant disease-free survival
Fig. 3
Fig. 3
Kaplan–Meier Overall survival between time periods. a Overall survival between time periods; b overall survival between age groups and time periods
Fig. 4
Fig. 4
Kaplan–Meier disease-free survival between time periods. a Overall disease-free survival by time; b overall disease-free survival by age and time; c locoregional disease-free survival by time; d distant disease-free survival by time

References

    1. Cancer of the Esophagus - Cancer Stat Facts. SEER, https://seer.cancer.gov/statfacts/html/esoph.html (accessed 13 May 2020).
    1. Chang AC, Lee JS. Resection for Esophageal Cancer in the Elderly. Thorac Surg Clin 2009; 19: 333–343. - PMC - PubMed
    1. Farrow NE, Raman V, Jawitz OK, et al. Impact of Age on Surgical Outcomes for Locally Advanced Esophageal Cancer. The Annals of Thoracic Surgery 2021; 111: 996–1003. - PMC - PubMed
    1. Cijs TM, Verhoef C, Steyerberg EW, et al. Outcome of esophagectomy for cancer in elderly patients. Ann Thorac Surg 2010; 90: 900–907. - PubMed
    1. Schlottmann F, Strassle PD, Nayyar A, et al. Postoperative outcomes of esophagectomy for cancer in elderly patients. Journal of Surgical Research 2018; 229: 9–14. - PubMed

Publication types